Why the study?
Does vasodilator therapy alter the clinical course of acute myocardial infarction?
Does vasodilator therapy alter the clinical course of acute myocardial infarction?
Discusses the pathophysiological rationale for using vasodilator therapy to manage left ventricular function and systemic vascular resistance in acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Rationale supports vasodilator consideration in AMI via LV function and SVR; leaves open whether therapy alters clinical course.
Recent interest in pharmacologic interventions to alter the course of acute myocardial infarction has led to the consideration of arterial pressure and systemic vascular resistance as factors controlling left ventricular function. In the first 24 hours after the onset of symptoms, the circulatory pattern of extensive transmural acute myocardial infarction is characterized by increased left ventricular end-diastolic pressure, reduced stroke volume and normal or even elevated arterial pressure.1 Maintenance of the arterial pressure in the face of a reduction in cardiac output implies an increase in peripheral resistance that may, in part, represent the vascular consequence of activation of the . . .
No takes yet. Share an insight, caveat, or question.
Jay N. Cohn (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: